The term “pseudodementia” has attracted much controversy. An elderly man with major depressive disorder, single episode, was misdiagnosed with dementia and subsequently Parkinson’s disease, A trial of high-dose Selegiline at 60 mg per day produced substantial improvement with complete resolution of cognitive impairment and disappearance of signs of “Parkinson’s disease”.